11/28/25 - #532

Good morning. In today’s edition:

• Peanut Allergies Have Plummeted Among US Kids Since 2017 – What Happened?

• Novo Chops Wegovy Prices, but Doctors Still See Affordability Challenges for Patients

• A Study Shows That Other Specified Feeding or Eating Disorder (OSFED) is as Harmful as Anorexia and Bulimia, Often Presenting With More Severe Symptoms, Despite Often Being Viewed as a Less Serious Disease

• Anxiety is One of the World’s Most Common Health Issues. How Have Treatments Evolved Over the Last 70 Years?

…and lots more. Have a great day!

Still Dealing with Hemorrhoids? You’re Not Alone.

The itching, burning, swelling—it’s more than uncomfortable. It’s exhausting. You’ve tried creams, wipes, even embarrassing treatments that promised relief... but the pain keeps coming back. Sound familiar?

Hem Hero® was made for you.

This natural supplement works from the inside out to help reduce swelling, relieve discomfort, and support healthy circulation—so you can finally stop worrying about flare-ups.

🌿 Powerful, plant-based formula
💊 Easy-to-swallow capsules (no mess!)
🕵️‍♂️ Discreet and effective—you don’t need to talk about it
🏃‍♀️ Fast relief that fits your life, not your bathroom cabinet

Unlike creams that only mask symptoms, Hem Hero® supports vein health and comfort where it matters most.

Over 100,000 people have trusted Hem Hero® and the Hem Healer® family for simple, science-backed support—and many say they wish they found it sooner.

✅ Free shipping on orders $79.99+
✅ Save 10% with a flexible subscription (cancel anytime)
✅ Just 1 capsule in the morning, 2 in the evening—done

🎯 Don’t let hemorrhoids run your life. Try Hem Hero® today and feel the difference.

FOOD & NUTRITION

Peanut Allergies Have Plummeted Among US Kids Since 2017 – What Happened?

Peanut allergies in children have dropped by more than 40% since 2017. That’s great news for parents and grandparents. What caused this big change?

For years, parents were told to avoid giving peanuts to babies. The idea was that waiting would help prevent allergies. But a major 2015 study showed the opposite. Babies who were given small amounts of peanut early—between 4 and 6 months old—were much less likely to become allergic. In fact, early introduction cut the risk by over 80%.

As a result, health experts changed the guidelines in 2017. Now, doctors suggest feeding small amounts of peanut to babies once they can sit up and swallow safely. This is especially helpful for babies with eczema or egg allergies, who are at higher risk for peanut allergy.

When someone has a peanut allergy, their immune system treats peanuts like a threat. This causes reactions like rashes, swelling, vomiting, or trouble breathing. But giving peanuts early may help the immune system learn that peanuts are safe.

Experts recommend starting with small tastes—like peanut butter thinned with water or special peanut snacks made for babies. Whole peanuts and thick peanut butter should be avoided at first, as they can be a choking risk. Always watch for signs of a reaction and talk to your doctor if your child is high-risk.

This drop in peanut allergies shows that early feeding changes can make a big difference.

Disclaimer: This article is for general information. Talk to your doctor before changing your child’s diet.

Source: yahoo.com

WEIGHT LOSS

Novo Chops Wegovy Prices, but Doctors Still See Affordability Challenges for Patients

Wegovy, a popular weight-loss shot, just got cheaper. Drugmaker Novo Nordisk cut the monthly price for higher doses to $349, down from $499, for people paying without insurance. They’re also offering the first two months of low-dose Wegovy or Ozempic for $199.

This move follows pressure from the Trump administration to bring drug prices down. Rival drugmaker Eli Lilly also plans price cuts. Its weight-loss drug, Zepbound, will start at $299, with other doses up to $449.

Even with price drops, many patients still can’t afford these drugs. A recent survey found about half of users say the cost is hard to manage. Experts say most people struggle to pay more than $100 a month for any medication.

People on Medicaid may not get help at all. Some states don’t cover weight-loss drugs, even if the person needs them. Doctors say this leaves many patients stuck.

That may change in 2026. Medicare, the government program for people 65 and older, will begin covering these drugs for those with serious weight-related health problems. Patients who qualify will pay $50 a month.

Novo Nordisk says this change, along with expanded Medicaid coverage, could help 40 million more Americans get access.

Still, some doctors say cost will stay a problem for many. Until more plans offer coverage, people may be forced to go without.

Disclaimer: This article is for informational purposes only. Always talk to your doctor before starting any new medication.

Source: apnews.com

HEALTH

A Study Shows That Other Specified Feeding or Eating Disorder (OSFED) is as Harmful as Anorexia and Bulimia, Often Presenting With More Severe Symptoms, Despite Often Being Viewed as a Less Serious Disease

A new study shows that a lesser-known eating disorder called OSFED can be just as harmful as anorexia or bulimia. In some cases, it may even be worse.

OSFED stands for “Other Specified Feeding or Eating Disorder.” It’s the most common eating disorder in the world. People with OSFED may not meet the full medical rules for anorexia or bulimia, but their struggles are still very real.

Researchers from McGill University looked at data from 836 adults with eating disorders. They found that people with OSFED had the same, or sometimes worse, symptoms of anxiety, depression, and poor body image as those with anorexia or bulimia.

Many people see OSFED as a “mild” disorder, but that’s not true. It can be just as serious. Some people don’t ask for help because they don’t think their problem is bad enough. But experts say anyone struggling with eating issues should be taken seriously.

For example, someone with OSFED may restrict food like a person with anorexia but not be underweight. Or they may purge often, like someone with bulimia, but not binge eat.

Up to 1 in 9 young people may have OSFED. Experts say more awareness is needed in clinics and the public.

“We need to take OSFED seriously,” said study leader Linda Booij. “Even if someone doesn’t fit a strict diagnosis, they still deserve care.”

If you’re struggling with food or body image, talk to a doctor. Help is available.

Source: mcgill.ca

Anxiety is One of the World’s Most Common Health Issues. How Have Treatments Evolved Over the Last 70 Years?

Anxiety is one of the most common health problems in the world. About 1 in 3 adults in the U.S. will deal with it at some point. Over the last 70 years, treatments for anxiety have changed a lot.

In the 1950s, doctors used drugs called tranquilizers like Miltown. These helped people feel calmer but had risks like addiction.

In the 1960s and 1970s, a new type of drug called benzodiazepines became popular. Valium and Xanax are examples. These worked fast and helped with panic attacks. But they also caused problems like dependency, so doctors became more careful with them.

In the 1990s, antidepressants like Prozac and Zoloft became common for treating anxiety. These drugs work slowly but are safer for long-term use. Another group of drugs called SNRIs also came out. They help with mood, focus, and energy.

The last new anxiety drug approved in the U.S. was duloxetine in 2004. Since then, no new anxiety drugs have been approved. Doctors often use other drugs “off-label,” meaning they’re not officially for anxiety but may still help.

Other options, like therapy and virtual reality treatments, are growing. But experts say more new treatments are needed.

Today’s medicines help many people, but not everyone. If you have anxiety, talk to a doctor about what may work best for you.

Disclaimer: This article is for general information only. Always talk to your doctor before starting or stopping any treatment.

Source: ourworldindata.org

✢ A Note From Hem Hero

The information in this health newsletter is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment; always consult your healthcare provider with any questions or concerns you may have regarding your health. The publishers are not responsible for any actions taken by the reader based on the information provided.